Comprehensive Cancer Center researchers continually look to the future with hope. Our physicians are actively involved in clinical trials that range from large, nationwide studies to small, innovative trials of new treatments. Our patients have access to promising, new treatments through participation in these cutting-edge cancer trials.
We currently have more than 30 studies available for patient enrollment. Depending on the site and stage of their cancer, patients may be eligible for participation, which may include treatment using chemotherapy, radiation therapy, surgery, or a combination of treatments. Studies are currently available for patients who have been diagnosed with breast, gastrointestinal, head and neck, genitourinary, melanoma and lung cancers, as well as for those with leukemia or lymphoma.
Our COBRE Center for Cancer Research Development (CCRD) is the only hospital-based center for cancer research in Rhode Island that is funded by the National Institutes of Health. The mission of the COBRE CCRD is to reduce cancer incidence and mortality in Rhode Island and southeastern Massachusetts through the application of new knowledge obtained during research studies. The center's renowned senior scientists mentor the next generation of cancer researchers, ensuring the center's mission perseveres for years to come.
Through the Brown-Lifespan partnership, Comprehensive Cancer Center physicians actively participate in the Brown University Oncology Group (BrUOG), a unique regional clinical trials network. BrUOG provides highly innovative approaches to cancer care.
Research studies and clinical trials